Imetelstat therapy in refractory anemia with ring sideroblasts with or without thrombocytosis

Схожие документы

• Refractory anemia with ring sideroblasts and thrombocytosis
  по: Pradhan, Sarita
  Опубликовано: (2017)
• Refractory Anemia with Ring Sideroblasts (RARS) and RARS with Thrombocytosis (RARS-T) – “2017 Update on Diagnosis, Risk-stratification, and Management”
  по: Patnaik, Mrinal M., et al.
  Опубликовано: (2017)
• Refractory Anemia with Ring Sideroblasts (RARS) and RARS with Thrombocytosis (RARS-T) – “2019 Update on Diagnosis, Risk-stratification, and Management”
  по: Patnaik, Mrinal M., et al.
  Опубликовано: (2019)
• Clinical features and course of refractory anemia with ring sideroblasts associated with marked thrombocytosis
  по: Broseus, Julien, et al.
  Опубликовано: (2012)
• Mutations of JAK2 and TET2, but not CBL are detectable in a high portion of patients with refractory anemia with ring sideroblasts and thrombocytosis
  по: Flach, Johanna, et al.
  Опубликовано: (2010)